MORE ABOUT THIS BOOK
Main description:
Advances in Clinical Chemistry, Volume 71, is the latest installment in this internationally acclaimed series. This latest volume contains chapters authored by world-renowned clinical laboratory scientists, physicians, and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry and is the benchmark for novel analytical approaches in the clinical laboratory.
Contents:
Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
Michael J. Duffy, Siun Walsh, Enda W. McDermott and John Crown
Polycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA
Ioana R. Ilie and Carmen E. Georgescu
EN2 in Prostate Cancer
Sophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.
Cytochrome P450 in Cancer Susceptibility and Treatment
Balraj Mittal, Sonam Tulsyan, Surendra Kumar, Rama Devi Mittal and Gaurav Agarwal
The Importance of Accurately Assessing Renal Function in the Neonate and Infant
Guido Filler, Laudelino Lopes and Mark Awuku
Systematic Assessment of the Hemolysis Index: Pros and Cons
Giuseppe Lippi
Peroxisome Proliferator-Activated Receptor a in Lipid Metabolism and Atherosclerosis Xiao-Hua Yu, Xi-Long Zheng and Chao-Ke Tang
PRODUCT DETAILS
Publisher: Elsevier (Academic Press Inc)
Publication date: September, 2015
Pages: 232
Weight: 510g
Availability: Available
Subcategories: Diseases and Disorders, General Issues, Medical Diagnosis